Navigation Links
Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien
Date:9/17/2013

made into the Dow Jones Sustainability World Index and North America Index. The Company informed that it has been also selected as leader in its specific DJSI industry sector, Health Care Equipment & Supplies, with overall score of 82, which was significantly higher than the average score of 39 for other companies in the sector. The Company further added that it also earned the highest scores across all three main areas of evaluation, including economic, environmental, and social performance. Katherine Pickus, Divisional Vice President, Global Citizenship and Policy at Abbott, said, "Abbott's strong performance in the DJSI is a reflection of the company's longstanding commitment to responsible and transparent business practices. Abbott strives to foster economic, environmental and societal well-being through our products, our core business operations and our partnerships with others." The Full Research Report on Abbott Laboratories - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-13/ABT]

Actavis Inc. Research Report

On September 12, 2013, Actavis Inc. (Actavis) announced that it has launched Oxymorphone Hydrochloride Extended-release tablets 5mg, 10mg, 30 mg, and 40 mg. The Company informed that Actavis' ANDA product is the generic equivalent to the previously marketed formulation of Endo Health Solutions' (Endo) Opana ER - an opioid agonist indicated for the relief of moderate to severe pain in patients requiring continuous around-the-clock opioid treatment for an extended period of time. Actavis stated that Opana ER was voluntarily withdrawn from sale in 2012 by Endo. According to the Company, currently, Actavis is a defendant in a lawsuit filed by Endo alleging that Actavis' Oxymorphone Hydrochloride Extended-release product infringes c
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Celtaxsys Announces Successful Completion of Phase 1 Clinical Trial for Development of CTX-4430
2. KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization
3. Arrayit Corporation Holds Successful Meeting with DHK Medical Products CEO
4. New Blood Clot Removal System Successfully Restores Blood Flow
5. Charleston Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting on New Migraine Treatment CL-H1T
6. Educating Key Stakeholder to Support a Successful Diabetes Product Launch
7. Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories
8. Varian Software Successfully Connected with Siemens Linear Accelerators
9. Marken Successfully Launches Quality Agreement Workshop Series
10. Following the Successful Launch in the United States, the New Simbionix U/S Mentor to be Introduced for the First Time in Europe
11. Inspiro Medical Ltd. Completes a Successful First Clinical Trial in Asthmatic Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
(Date:5/1/2015)...  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a specialty ... innovative therapies for the treatment of acute and breakthrough ... chief financial officer  will be participating in three upcoming ... Mizuho Third Annual Healthcare Corporate Access Day ... New York Bank ...
(Date:5/1/2015)... May 1, 2015  Shares of Aerie Pharmaceuticals, Inc. ... value yesterday following the results of the Phase 3 ... Despite the trial failing to meet its end points, ... may come from future studies. An analyst ... current pipeline, financial review, analyst summary, valuation, and recommendation ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... , ALISO VIEJO, Calif., Nov. 17 OCTANe hosted ... companies to discuss promising technology and emerging trends for the ... Medical Device & Investor Forum. , For the first ... transactions in Orange County history discussed the details of the ...
... , NEW YORK, Nov. 17 Engineer/pilot/attorney Jon Roberts, ... They include technology that thwarts piracy in movie theatres, ... to enhance airport security and even an electronic matchmaker ... they have, indeed, found their match. Now, as ...
Cached Medicine Technology:OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities 2When Viruses (Including H1N1) and Bacteria are as Close as your Fingertips; VirWall's New Innovation Can Disarm Killer Keyboards 2
(Date:5/2/2015)... (PRWEB) May 02, 2015 ZoomCare, the ... has submitted plans to offer its new healthcare insurance ... The ZOOM+ Personal Health Insurance System is the nation’s ... to enhance human performance. ZOOM+ Personal Health Insurance was ... delivery system that are subject to review and regulation ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Pioneer Millworks, ... share the latest in their reclaimed wood products at ... the Jacob Javits Center in NYC this May. Their ... will bring much anticipated texture and color to North ... an explosion of texture and color in the design ...
(Date:5/1/2015)... Mesa, CA (PRWEB) May 01, 2015 ... at the Cerner Southeast Regional User Group (RUG) Conference ... The Cerner Southeast Regional User Group Conference provides a ... to vendors who support all aspects of electronic medical ... use of Cerner software applications. , In addition to ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
(Date:5/1/2015)... Digital technology and Wi-Fi-enabled medical equipment may ... appointments, a preliminary study has shown. ... low-risk pregnant women, will be presented as a poster ... Associates at the 2015 American Congress of Obstetricians and ... The digital technology used was developed by Babyscripts™ ...
Breaking Medicine News(10 mins):Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... comes to estimating calorie counts, Americans aren,t really on ... Journal of Consumer Research , this may be ... food. "The sequence in which items are considered ... Alexander Chernev (Northwestern University). "The focus on sequential estimation ...
... By Kathleen Doheny HealthDay Reporter ... new studies may help breast cancer patients and ... reconstruction after mastectomy. One study finds that ... after having had a mastectomy with immediate reconstruction ...
... ultimate goal to discover a drug that one day treats ... on pinpointing the mechanisms in the brain that respond to ... in the UH College of Pharmacy, received a three-year, $450,000 ... In the end, his team hopes their research will help ...
... of prostate tumors, promotes the growth of a different type ... online on September 20 in the Journal of Experimental ... and colleagues find that TAL1, a protein abundantly expressed in ... (T-ALL), drives expression of NKX3.1. Eliminating NKX3.1 halted the ...
... might not benefit from some of the tuberculosis vaccines currently ... are designed to activate a specific molecule that is an ... people. But a recent Ohio State University study suggests that ... the face of TB infection. The animal research suggests ...
... of Utah determined that the 2009 pandemic influenza A ... children than the seasonal flu. The most common ... of the study, the most extensive evaluation of neurological ... the September issue of Annals of Neurology , ...
Cached Medicine News:Health News:Low-calorie cheesecake? Why we have trouble estimating calories 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:Drug to treat alcoholism goal of UH professor's research 2Health News:Elderly might not benefit from TB vaccines in development 2Health News:Elderly might not benefit from TB vaccines in development 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: